SMTL ID : 3w1f.1

Crystal structure of Human MPS1 catalytic domain in complex with 5-(5-ethoxy-6-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-3-yl)-2-methylbenzenesulfonamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x 1O5: 5-[5-ethoxy-6-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-3-yl]-2-methylbenzenesulfonamide(Non-covalent)

1O5.1: 16 residues within 4Å: Chain A: K.15, I.17, V.25, Q.27, A.37, K.39, E.57, L.61, M.88, E.89, C.90, G.91, N.92, L.140, I.149, M.157 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.17, A:V.25, A:A.37, A:L.140, A:I.149, A:M.157 Hydrogen bonds: A:K.15, A:Q.27, A:K.39, A:E.89, A:G.91, A:N.92

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kusakabe, K. et al., Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125). J.Med.Chem. (2013)

Release Date

2013-06-26

Peptides

Dual specificity protein kinase TTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity protein kinase TTK

Related Entries With Identical Sequence